The advent of advanced genetic editing technologies, particularly CRISPR-Cas9, has ushered in a new era of possibilities in assisted reproduction. These tools offer unprecedented precision in modifying the human genome, raising profound questions about the boundaries of scientific intervention in human life. While the potential for eradicating inherited diseases is immense, the ethical and legal implications are equally vast and complex, demanding careful consideration and robust regulatory frameworks. This article delves into the intricate scientific underpinnings of genetic editing in assisted reproduction, explores the multifaceted ethical debates it engenders, and examines the evolving legal landscape attempting to govern this rapidly advancing field. We will analyze the distinctions between somatic and germline editing, discuss the "designer baby" conundrum, and consider the challenges in forging a globally harmonized regulatory path for the future. A conceptual ...